PR Newswire PharmaOriginal article
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
EarningsLeqembiPositive
AI Analysis
Summary
BioArctic's partner Eisai reported Leqembi Q2 2026 sales of 29.3 billion yen in conjunction with Biogen's quarterly earnings announcement.
Financial Highlights
Revenue
29.3 billion yen (Leqembi Q2 2026)
Outcome Details
Q2 2026 revenue reported
Importance:5/10
Sentiment:
0.50
LeqembiQ2 2026 earningsRevenue reportingPartnership
Related Companies
Read the original article
Published by PR Newswire Pharma on July 29, 2026 10:27 AM